The Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South Florida
The Oncology Institute (NASDAQ: TOI) has announced a strategic partnership with Doctors HealthCare Plans to enhance oncology care management in South Florida. TOI will provide delegated utilization management services and clinical advisory support for the Medicare Advantage plan's members.
Under this collaboration, TOI will manage oncology services using its clinical protocols, medical director oversight, and technology-enabled workflows. The partnership aims to support optimal oncology benefit design and evidence-based care pathways, building on TOI's successful track record of managing medical cost risk across multiple states.
The partnership focuses on ensuring patients receive appropriate care while improving outcomes and maintaining cost effectiveness in the healthcare system.
The Oncology Institute (NASDAQ: TOI) ha annunciato una collaborazione strategica con Doctors HealthCare Plans per potenziare la gestione delle cure oncologiche nel sud della Florida. TOI fornirà servizi delegati di gestione dell’utilizzo e supporto di consulenza clinica per i membri del piano Medicare Advantage.
Nel quadro di questa collaborazione, TOI gestirà i servizi oncologici avvalendosi dei propri protocolli clinici, della supervisione del direttore medico e di flussi di lavoro abilitati dalla tecnologia. La partnership mira a supportare un design ottimale dei benefit oncologici e percorsi di cura basati sull’evidenza, facendo leva sul comprovato successo di TOI nella gestione del rischio dei costi medici in diversi stati.
L’accordo si concentra sull’assicurare che i pazienti ricevano cure appropriate, migliorando gli esiti e mantenendo l’efficacia dei costi nel sistema sanitario.
The Oncology Institute (NASDAQ: TOI) ha anunciado una alianza estratégica con Doctors HealthCare Plans para mejorar la gestión de la atención oncológica en el sur de Florida. TOI proporcionará servicios delegados de gestión de utilización y asesoramiento clínico para los miembros del plan Medicare Advantage.
En el marco de esta colaboración, TOI gestionará los servicios oncológicos empleando sus protocolos clínicos, la supervisión de su director médico y flujos de trabajo habilitados por tecnología. La asociación busca respaldar un diseño óptimo de los beneficios oncológicos y rutas de atención basadas en la evidencia, apoyándose en el historial de TOI en la gestión del riesgo de costos médicos en varios estados.
La alianza se centra en garantizar que los pacientes reciban la atención adecuada, mejorando los resultados y manteniendo la eficiencia de costos en el sistema sanitario.
The Oncology Institute (NASDAQ: TOI)는 Doctors HealthCare Plans와 전략적 파트너십을 체결해 남부 플로리다의 암 치료 관리 역량을 강화한다고 발표했습니다. TOI는 Medicare Advantage 플랜 가입자들에게 위임된 이용관리 서비스와 임상 자문 지원을 제공합니다.
이번 협력 아래 TOI는 자체 임상 프로토콜, 의학 책임자 감독 및 기술 기반 워크플로를 활용해 암 관련 서비스를 관리합니다. 이 파트너십은 TOI가 여러 주에서 의료비 위험 관리를 성공적으로 수행해온 경험을 바탕으로, 근거 중심의 치료 경로와 최적의 암 보장 설계를 지원하는 것을 목표로 합니다.
파트너십은 환자가 적절한 치료를 받도록 보장하면서 결과를 개선하고 의료 체계의 비용 효율성을 유지하는 데 중점을 둡니다.
The Oncology Institute (NASDAQ: TOI) a annoncé un partenariat stratégique avec Doctors HealthCare Plans pour renforcer la gestion des soins oncologiques dans le sud de la Floride. TOI fournira des services délégués de gestion de l'utilisation et un support de conseil clinique aux membres du plan Medicare Advantage.
Dans le cadre de cette collaboration, TOI prendra en charge la gestion des services oncologiques en s’appuyant sur ses protocoles cliniques, la supervision du directeur médical et des workflows assistés par la technologie. Le partenariat vise à soutenir une conception optimale des prestations oncologiques et des parcours de soins fondés sur les preuves, en s'appuyant sur le bilan probant de TOI en matière de gestion des risques de coûts médicaux dans plusieurs États.
Le partenariat met l’accent sur la garantie d’un accès à des soins appropriés pour les patients, l’amélioration des résultats et le maintien de l’efficience des coûts dans le système de santé.
The Oncology Institute (NASDAQ: TOI) hat eine strategische Partnerschaft mit Doctors HealthCare Plans angekündigt, um das Onkologie-Management in Südflorida zu verbessern. TOI wird delegierte Utilization-Management-Dienstleistungen und klinische Beratung für die Mitglieder des Medicare Advantage-Plans bereitstellen.
Im Rahmen dieser Zusammenarbeit wird TOI onkologische Leistungen mithilfe eigener klinischer Protokolle, der Aufsicht durch den medizinischen Direktor und technologiegestützter Arbeitsabläufe steuern. Ziel der Partnerschaft ist es, ein optimales Design der onkologischen Leistungen und evidenzbasierte Versorgungswege zu unterstützen, gestützt auf TOIs erfolgreiche Bilanz bei der Steuerung medizinischer Kostenrisiken in mehreren Bundesstaaten.
Der Schwerpunkt der Partnerschaft liegt darauf, sicherzustellen, dass Patienten angemessene Versorgung erhalten, die Ergebnisse verbessert werden und Kosteneffizienz im Gesundheitssystem bewahrt bleibt.
- Strategic expansion into South Florida Medicare Advantage market
- Leverages TOI's existing expertise in managing medical cost risk
- Potential for cost savings while maintaining quality care
- None.
Insights
TOI's new partnership with Doctors HealthCare Plans expands its value-based oncology management footprint in Florida, strengthening recurring revenue potential.
This strategic partnership represents a meaningful expansion of TOI's value-based care business model. By providing delegated utilization management services to Doctors HealthCare Plans, TOI is effectively extending its expertise beyond direct patient care into the care management and cost containment side of oncology services. This approach allows TOI to generate revenue streams that aren't solely dependent on patient volume.
The partnership has several strategic advantages for TOI's business model. First, it leverages TOI's existing clinical protocols and technology infrastructure with minimal incremental cost. Second, it positions TOI as a partner to payers rather than just a provider, creating deeper integration into the healthcare ecosystem. Third, it demonstrates TOI's ability to scale its value proposition beyond its physical clinic locations.
This agreement aligns with the healthcare industry's continuing shift toward value-based arrangements. By managing utilization and providing clinical advisory services, TOI can help control costs while maintaining quality - precisely what Medicare Advantage plans need as they face ongoing pressure to manage medical loss ratios while improving star ratings. TOI's experience managing risk contracts across multiple states creates a competitive advantage in this growing market segment.
For investors, this partnership signals TOI's evolution beyond a traditional oncology practice into a more sophisticated healthcare services organization with multiple revenue streams and value creation mechanisms. While financial terms weren't disclosed, these utilization management contracts typically provide stable, recurring revenue that complements the more variable patient care revenue.
CERRITOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a national leader in value-based oncology care, is pleased to announce a strategic partnership with Doctors HealthCare Plans, a Medicare Advantage plan serving members across South Florida. The Oncology Institute will provide delegated utilization management services and clinical advisory support, helping Doctors HealthCare Plans ensure high-quality, cost-effective cancer care for their members.
Under this partnership, The Oncology Institute will deliver comprehensive utilization management functions for oncology services, leveraging its robust clinical protocols, medical director oversight, and technology-enabled workflows. The collaboration also includes advisory services to support optimal oncology benefit design and evidence-based care pathways, empowering the plan’s providers to deliver personalized and clinically appropriate treatment for every patient.
This partnership builds on TOI’s national track record of managing medical cost risk across diverse, value-based arrangements. TOI currently supports delegated risk contracts across multiple states and payer types, consistently achieving cost savings while improving quality and patient satisfaction.
“We are proud to support Doctors HealthCare Plans with our delegated UM and oncology advisory services,” said Dr. Dan Virnich, CEO of The Oncology Institute. “By combining our clinical expertise with a collaborative, data-driven approach to utilization management, we can help ensure that patients receive the right care at the right time, improving outcomes and supporting affordability across the system.”
“This partnership is a reflection of our ongoing commitment to provide high-quality, high-value care to our members,” said Brandon Haushalter, CEO of Doctors HealthCare Plans. “With TOI’s leadership in oncology management and value-based care, we’re confident this collaboration will bring greater transparency, clinical rigor, and support to our providers while enhancing the member experience.”
The partnership underscores a shared commitment to advancing oncology care through smarter utilization management, setting a new standard for how health plans and specialty providers can work together to improve the cancer care journey.
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
About Doctor's Healthcare Plans (https://www.doctorshcp.com/):
Doctors HealthCare Plans (DHCP) is a Florida-based, locally owned and operated Medicare Advantage Health Plan offering coverage for eligible Medicare beneficiaries across Miami-Dade and Broward County. The health plan was founded on a deep commitment to the community and provides an extensive network of providers, pharmacies, and hospitals. DHCP’s mission is to develop and establish a healthcare organization that is responsive and attentive to the needs of all beneficiaries by offering high-quality and cost-effective health care services.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
FAQ
What services will TOI provide to Doctors HealthCare Plans?
How will this partnership benefit Doctors HealthCare Plans members?
What is TOI's experience in managing medical cost risk?
Who are the key executives involved in the TOI-Doctors HealthCare Plans partnership?
What geographical area does this TOI partnership cover?
